Correction: Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
2017 · Nature Communications · 268 citations
https://doi.org/10.1038/ncomms16165
B
Bert Schepens
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
87
Papers
4.8K
Citations
38
h-index
59
i10-index
Bert Schepens is an academic researcher from University College Ghent. The author has contributed to research in topics: Influenza Virus Research Studies & Monoclonal and Polyclonal Antibodies Research & Respiratory viral infections research. The author has an h-index of 38, co-authored 74 publications.
ORCID: 0000-0002-2028-1984Papers by this author
worksA role for hnRNP C1/C2 and Unr in internal initiation of translation during mitosis
2006 · The EMBO Journal · 106 citations
https://doi.org/10.1038/sj.emboj.7601468
Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human Macrophages
2016 · Molecular & Cellular Proteomics · 76 citations
https://doi.org/10.1074/mcp.m116.057984
Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies
2016 · Scientific Reports · 51 citations
https://doi.org/10.1038/srep24402
Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice
2019 · Journal of Translational Medicine · 29 citations
https://doi.org/10.1186/s12967-019-1991-3
Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base
2025 · Nature Communications · 8 citations
https://doi.org/10.1038/s41467-025-60250-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat